Lisa Feng, M.B.A.Head of Asia & President, EXUMA Hong Kong

Ms. Feng joined EXUMA Biotech in June 2024 and serves as Head of Asia and President of EXUMA Biotechnology Hong Kong.  Prior to joining EXUMA, she was Chief Financial Officer and Chief Business Officer at Zhaoke Ophthalmology, a Hong Kong publicly traded company.  At Zhaoke, she oversaw business strategy in addition to being responsible for the finance, investor relations, HR, IT/digital and legal functions.

Ms. Feng began her career in the US at McKinsey, followed by a decade in investment banking, including eight years at Goldman Sachs and two years at Standard Chartered Bank as its head of China Equity Capital Markets.  Her banking experience includes M&A, IPO and debt/equity financing transactions.  Prior to Zhaoke, she served as Chief Financial Officer of ACEA Therapeutics, a small molecule oncology company.

Ms. Feng received her bachelor’s and master’s degrees in computer science from Fudan University (China) and University of Virginia (US) respectively, and her MBA degree from University of Chicago Booth School of Business (US).